These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 823275)
1. Tobramycin in treatment of infections due to Pseudomonas aeruginosa in patients with cystic fibrosis. Crozier DN; Khan SR J Infect Dis; 1976 Aug; 134 Suppl():S187-90. PubMed ID: 823275 [TBL] [Abstract][Full Text] [Related]
2. Tobramycin and carbenicillin compared with gentamicin and carbenicillin in the treatment of infection with Pseudomonas aeruginosa in adult patients with cystic fibrosis. Hodson ME; Wingfield HJ; Batten JC Br J Dis Chest; 1983 Jan; 77(1):71-7. PubMed ID: 6407508 [TBL] [Abstract][Full Text] [Related]
3. Gentamicin and tobramycin compared in the treatment of mucoid pseudomonas lung infections in cystic fibrosis. Martin AJ; Smalley CA; George RH; Healing DE; Anderson CM Arch Dis Child; 1980 Aug; 55(8):604-7. PubMed ID: 7436516 [TBL] [Abstract][Full Text] [Related]
4. Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis. Parry MF; Neu HC J Infect Dis; 1976 Aug; 134 Suppl():S194-7. PubMed ID: 823276 [TBL] [Abstract][Full Text] [Related]
5. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis. Cheer SM; Waugh J; Noble S Drugs; 2003; 63(22):2501-20. PubMed ID: 14609360 [TBL] [Abstract][Full Text] [Related]
6. Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis. Barclay ML; Begg EJ; Chambers ST; Thornley PE; Pattemore PK; Grimwood K J Antimicrob Chemother; 1996 Jun; 37(6):1155-64. PubMed ID: 8836818 [TBL] [Abstract][Full Text] [Related]
7. Tobramycin therapy of infections due to Pseudomonas aeruginosa in patients with cystic fibrosis: effect of dosage and concentration of antibiotic in sputum. McCrae WM; Raeburn JA; Hanson EJ J Infect Dis; 1976 Aug; 134 Suppl():S191-3. PubMed ID: 972281 [TBL] [Abstract][Full Text] [Related]
8. A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study. Chuchalin A; Csiszér E; Gyurkovics K; Bartnicka MT; Sands D; Kapranov N; Varoli G; Monici Preti PA; Mazurek H Paediatr Drugs; 2007; 9 Suppl 1():21-31. PubMed ID: 17536872 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of chronic infections with mucoid Pseudomonas aeruginosa in lower airways of patients with cystic fibrosis. Friis B Scand J Infect Dis; 1979; 11(3):211-7. PubMed ID: 118525 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. Møller NE; Høiby N Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884 [TBL] [Abstract][Full Text] [Related]
11. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis. Pedersen SS; Pressler T; Jensen T; Rosdahl VT; Bentzon MW; Høiby N; Koch C J Antimicrob Chemother; 1987 Jan; 19(1):101-7. PubMed ID: 3104273 [TBL] [Abstract][Full Text] [Related]
12. Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Lenoir G; Antypkin YG; Miano A; Moretti P; Zanda M; Varoli G; Monici Preti PA; Aryayev NL Paediatr Drugs; 2007; 9 Suppl 1():11-20. PubMed ID: 17536871 [TBL] [Abstract][Full Text] [Related]
13. TOBI Podhaler for cystic fibrosis patients with Pseudomonas aeruginosa. Farinde A Nurse Pract; 2015 Jul; 40(7):16-7. PubMed ID: 26080292 [No Abstract] [Full Text] [Related]